Opportunity Information: Apply for RFA FD 18 023

Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01) (Funding Opportunity Number RFA-FD-18-023) is a discretionary federal funding opportunity from the U.S. Department of Health and Human Services, Food and Drug Administration (FDA), specifically aligned with the work of the Center for Biologics Evaluation and Research (CBER). The program is focused on advancing the manufacturing science behind complex biologic products by supporting active research that applies novel, emerging technologies to how these products are made and how their quality is evaluated. In practice, the goal is to strengthen modern manufacturing capabilities for biologics by encouraging new approaches that can improve robustness, consistency, and overall product quality.

The core purpose of the opportunity is to accelerate innovation in advanced manufacturing for complex biologics, paired with innovative analytical methods that help characterize products and monitor manufacturing processes. The emphasis on both manufacturing technologies and analytical approaches reflects a full lifecycle view of quality: improving how biologics are produced while also improving the tools used to measure, verify, and maintain quality during development and production. This kind of research can include work that enables better process control, improved detection of quality attributes, or more informative measurements that help manufacturers understand variability and reduce risk to product consistency.

This opportunity uses a cooperative agreement as the funding instrument type, meaning the FDA anticipates substantial involvement with recipients beyond what is typical for a more hands-off grant. While applicants would still conduct independent research, the cooperative structure generally signals an expectation of ongoing collaboration, coordination, or technical engagement with the agency to ensure the research aligns with program priorities and delivers outputs that are broadly useful to the biologics manufacturing and regulatory science landscape.

The opportunity falls under the funding activity category of Consumer Protection and Health, and is associated with CFDA number 93.103. It was created on April 23, 2018, with an original application closing date of June 25, 2018. The maximum award amount listed (award ceiling) is $600,000, and the FDA expected to make about 5 awards under this announcement, indicating a competitive program designed to fund a small number of projects with clear relevance and strong technical merit.

Eligibility is broad and includes many types of organizations that can contribute to advanced manufacturing research. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. This wide eligibility suggests the program is intended to draw from academia, industry, nonprofits, and government entities that have relevant manufacturing, bioprocessing, analytical chemistry, bioengineering, or related expertise.

Overall, RFA-FD-18-023 is aimed at pushing the state of the art in how complex biologic products are manufactured and evaluated, with the FDA/CBER supporting research that can lead to more advanced, reliable, and quality-focused manufacturing approaches. The practical value of the funded work would be in generating knowledge, methods, or technologies that make biologic production more modern and resilient while improving the analytical foundations needed to demonstrate and maintain product quality.

  • The Department of Health and Human Services, Food and Drug Administration in the consumer protection, health sector is offering a public funding opportunity titled "Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
  • This funding opportunity was created on Apr 23, 2018.
  • Applicants must submit their applications by Jun 25, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $600,000.00 in funding.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses.
Apply for RFA FD 18 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Manufacturing Companies

Browse more opportunities from the same agency: Department of Health and Human Services, Food and Drug Administration

Browse more opportunities from the same category: Consumer Protection, Health

Next opportunity: Chickasaw and Choctaw Student Media Internship

Previous opportunity: Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery (U01)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA FD 18 023

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA FD 18 023) also looked into and applied for these:

Funding Opportunity
Assuring Radiation Protection (U18) Clinical Trial Not Allowed Apply for RFA FD 23 018

Funding Number: RFA FD 23 018
Agency: Department of Health and Human Services, Food and Drug Administration
Category: Consumer Protection, Health
Funding Amount: $105,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 18 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: